Showing 261 - 280 results of 8,432 for search '(( significant all decrease ) OR ( significant ((side decrease) OR (we decrease)) ))', query time: 0.57s Refine Results
  1. 261

    Table 3_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

    Published 2025
    “…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I<sup>2</sup> = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I<sup>2</sup> = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I<sup>2</sup> = 65.5%). …”
  2. 262

    Table 1_Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors.pdf by Qingmei Gao (20905781)

    Published 2025
    “…In the context of all-cause mortality, the risk of death was found to be significantly lower in quartiles Q2, Q3 and Q4 when compared to the OBS in quartile Q1. …”
  3. 263

    Table 1_Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES.docx by Chengzhi Hou (20419865)

    Published 2024
    “…The higher levels of ALI and serum albumin were significantly associated with lower risks of all-cause and cardiovascular mortality among these individuals. …”
  4. 264

    Image 1_Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES.tif by Chengzhi Hou (20419865)

    Published 2024
    “…The higher levels of ALI and serum albumin were significantly associated with lower risks of all-cause and cardiovascular mortality among these individuals. …”
  5. 265
  6. 266

    Table 1_The association between oxidative balance scores and all-cause mortality and cancer-specific mortality in cancer survivors: a retrospective cohort study.doc by Ran He (207626)

    Published 2025
    “…</p>Conclusion<p>The study reveals a significant linear negative association between OBS in cancer survivors and both all-cause and cancer-specific mortality.…”
  7. 267
  8. 268

    Data Sheet 1_Association of oxidative balance score with all-cause and cardiovascular mortality among patients with cardio-renal-metabolic disease.docx by Yucui Lin (21598376)

    Published 2025
    “…Moreover, Higher OBS quartiles were linked to a decreased risk of cardiovascular mortality, while no significant reduction was observed in the lower quartiles [model 3: Q2, Q3, Q4: aHR (95CI%) = 0.96(0.77–1.19), 0.78 (0.63–0.97), 0.70 (0.53–0.93), respectively; P for trend = 0.003]. …”
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273

    Image 2_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

    Published 2025
    “…Fully adjusted Cox proportional hazards models demonstrated significant associations, indicating higher all-cause mortality risks in participants with both extremely low and high HGI levels compared to the Q2 group. …”
  14. 274

    Image 1_Hemoglobin glycation index and all-cause mortality in adults: insights from a decade-long prospective cohort study.tif by Yue-Yang Zhang (14258160)

    Published 2025
    “…Fully adjusted Cox proportional hazards models demonstrated significant associations, indicating higher all-cause mortality risks in participants with both extremely low and high HGI levels compared to the Q2 group. …”
  15. 275

    Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

    Published 2024
    “…Among them, W<sub>3</sub>BipY<sub>8</sub>-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W<sub>3</sub>BipY<sub>8</sub> but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W<sub>3</sub>BipY<sub>8</sub>. …”
  16. 276
  17. 277
  18. 278
  19. 279
  20. 280